|
|
|
|
Safety News Article Excerpt |
| |
| July 7, 2005 |
New York Times, "Study says malpractice
payouts aren't rising" |
When Mike Kreidler was an optometrist in
Olympia, Wash., he railed against trial lawyers. He believed that aggressive
trial lawyers were the reason he faced rising insurance premiums. Dr.
Kreidler, now in his second term as Washington State's insurance commissioner,
has changed his mind. He has decided that the problem is not the lawyers
- although they have contributed - but also the insurance companies. "I
came full circle," he said. "I started out with a strong bias
against trial lawyers and lawsuits, and now I see the trade-off and I
have both sides, the trial lawyers and the insurance companies, mad at
me."
The high price of medical malpractice insurance is a notoriously
nebulous and highly politicized subject. Insurers and doctors contend
that the insurance is more expensive because of a surge in jury awards
and settlements. Consumer advocates and their political allies assert
that insurers have raised rates because they can, arguing that insurers'
claims have slowed significantly while premiums have shot up.
A study
to be released today by the Center for Justice and Democracy, a consumer
advocacy group in New York, may add fuel to that debate. The study, compiled
from regulatory filings by insurers to state regulators, finds that net
claims for medical malpractice paid by 15 leading insurance companies
have remained flat over the last five years, while net premiums have
surged 120 percent. From 2000 to 2004, the increase in premiums collected
by the leading 15 medical malpractice insurance companies was 21 times
the increase in the claims they paid, according to the study. (The net
totals in the study are calculated after accounting for reinsurance.)
Of the 15 companies examined, 9 are mutual insurers owned by their policyholders,
3 have publicly traded stock but are part of larger conglomerates and
3 are publicly traded and focus primarily on medical malpractice. The
stock prices of those three companies have each risen more than 100 percent
since May 2002. "In recent years, medical malpractice hasn't been
unprofitable but it's been phenomenally profitable," said Jay Angoff,
the former state insurance commissioner of Missouri and a consultant
on the study. |
| July 20, 2005 |
Associated Press, "Man Awarded $2.7 million for Popcorn Plant Injuries" |
A former popcorn plant worker who claimed his respiratory illness was the result of a harmful chemical used to make butter flavoring has been awarded about $2.7 million in damages.
Kenneth Moenning, 36, of Lockwood, is one of about 30 current and former workers at Jasper Popcorn Co. who have sued International Flavors and Fragrances Inc. and subsidiary Bush Boake Allen Inc. The plaintiffs say the manufacturers should have known the chemical diacetyl, used to make the popcorn's butter flavoring, causes lung damage.
Moenning worked in the flavoring room at the Jasper plant from 1993 through 1995. Doctors testified he has bronchiolitis obliterans, a rare, progressive lung disease that eventually could require that he receive a lung transplant.
|
|
|
| Many of our cases start as the result of a complaint by
one or a handful of persons. If you have been harmed by a fraud or deceptive
practice, or injured by a dangerous or defective product, please feel free
to contact
us. |
| Lieff Cabraser Heimann & Bernstein, LLP is a fifty-plus
attorney law firm with offices in San Francisco, New York and Nashville. |
| Since 1972, Lieff Cabraser has successfully represented
plaintiffs in class actions, group and individual cases in the fields of personal
injury and mass torts, employment discrimination and unfair employment practices,
antitrust, consumer protection, defective products, securities and investment
fraud, environmental and toxic exposure, aviation disasters and civil and human
rights. |
| Our comprehensive and diverse practice is unique among law
firms that represent only plaintiffs. Learn more about
our firm. |
|
|
|
|